nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednicarbate—Dermatitis acneiform—Erlotinib—pancreatic cancer	0.0887	0.0887	CcSEcCtD
Prednicarbate—Telangiectasia—Fluorouracil—pancreatic cancer	0.0879	0.0879	CcSEcCtD
Prednicarbate—Leukoderma—Sunitinib—pancreatic cancer	0.0617	0.0617	CcSEcCtD
Prednicarbate—Allergic contact dermatitis—Fluorouracil—pancreatic cancer	0.0592	0.0592	CcSEcCtD
Prednicarbate—Folliculitis—Erlotinib—pancreatic cancer	0.0482	0.0482	CcSEcCtD
Prednicarbate—Secondary infection—Epirubicin—pancreatic cancer	0.0343	0.0343	CcSEcCtD
Prednicarbate—Eruption—Gemcitabine—pancreatic cancer	0.0342	0.0342	CcSEcCtD
Prednicarbate—Secondary infection—Doxorubicin—pancreatic cancer	0.0317	0.0317	CcSEcCtD
Prednicarbate—Eruption—Docetaxel—pancreatic cancer	0.0243	0.0243	CcSEcCtD
Prednicarbate—Leukoderma—Epirubicin—pancreatic cancer	0.0237	0.0237	CcSEcCtD
Prednicarbate—Leukoderma—Doxorubicin—pancreatic cancer	0.0219	0.0219	CcSEcCtD
Prednicarbate—Dermatitis contact—Fluorouracil—pancreatic cancer	0.0205	0.0205	CcSEcCtD
Prednicarbate—Eruption—Epirubicin—pancreatic cancer	0.0164	0.0164	CcSEcCtD
Prednicarbate—Folliculitis—Epirubicin—pancreatic cancer	0.016	0.016	CcSEcCtD
Prednicarbate—Eruption—Doxorubicin—pancreatic cancer	0.0152	0.0152	CcSEcCtD
Prednicarbate—Folliculitis—Doxorubicin—pancreatic cancer	0.0148	0.0148	CcSEcCtD
Prednicarbate—Oedema—Tamoxifen—pancreatic cancer	0.0109	0.0109	CcSEcCtD
Prednicarbate—Infection—Tamoxifen—pancreatic cancer	0.0109	0.0109	CcSEcCtD
Prednicarbate—Oedema—Erlotinib—pancreatic cancer	0.0108	0.0108	CcSEcCtD
Prednicarbate—Infection—Erlotinib—pancreatic cancer	0.0107	0.0107	CcSEcCtD
Prednicarbate—Dermatitis contact—Epirubicin—pancreatic cancer	0.00996	0.00996	CcSEcCtD
Prednicarbate—Paraesthesia—Tamoxifen—pancreatic cancer	0.00982	0.00982	CcSEcCtD
Prednicarbate—Oedema—Sunitinib—pancreatic cancer	0.00936	0.00936	CcSEcCtD
Prednicarbate—Pain—Tamoxifen—pancreatic cancer	0.00935	0.00935	CcSEcCtD
Prednicarbate—Infection—Sunitinib—pancreatic cancer	0.0093	0.0093	CcSEcCtD
Prednicarbate—Pain—Erlotinib—pancreatic cancer	0.00925	0.00925	CcSEcCtD
Prednicarbate—Dermatitis contact—Doxorubicin—pancreatic cancer	0.00922	0.00922	CcSEcCtD
Prednicarbate—Urticaria—Tamoxifen—pancreatic cancer	0.00868	0.00868	CcSEcCtD
Prednicarbate—Paraesthesia—Sunitinib—pancreatic cancer	0.00841	0.00841	CcSEcCtD
Prednicarbate—Pain—Sunitinib—pancreatic cancer	0.00801	0.00801	CcSEcCtD
Prednicarbate—Pruritus—Tamoxifen—pancreatic cancer	0.00773	0.00773	CcSEcCtD
Prednicarbate—Oedema—Irinotecan—pancreatic cancer	0.00771	0.00771	CcSEcCtD
Prednicarbate—Infection—Irinotecan—pancreatic cancer	0.00766	0.00766	CcSEcCtD
Prednicarbate—Pruritus—Erlotinib—pancreatic cancer	0.00765	0.00765	CcSEcCtD
Prednicarbate—Oedema—Gemcitabine—pancreatic cancer	0.00751	0.00751	CcSEcCtD
Prednicarbate—Infection—Gemcitabine—pancreatic cancer	0.00746	0.00746	CcSEcCtD
Prednicarbate—Oedema—Fluorouracil—pancreatic cancer	0.00739	0.00739	CcSEcCtD
Prednicarbate—Infection—Fluorouracil—pancreatic cancer	0.00734	0.00734	CcSEcCtD
Prednicarbate—Paraesthesia—Irinotecan—pancreatic cancer	0.00692	0.00692	CcSEcCtD
Prednicarbate—Rash—Tamoxifen—pancreatic cancer	0.00689	0.00689	CcSEcCtD
Prednicarbate—Dermatitis—Tamoxifen—pancreatic cancer	0.00689	0.00689	CcSEcCtD
Prednicarbate—Rash—Erlotinib—pancreatic cancer	0.00682	0.00682	CcSEcCtD
Prednicarbate—Dermatitis—Erlotinib—pancreatic cancer	0.00681	0.00681	CcSEcCtD
Prednicarbate—Paraesthesia—Gemcitabine—pancreatic cancer	0.00675	0.00675	CcSEcCtD
Prednicarbate—Paraesthesia—Fluorouracil—pancreatic cancer	0.00663	0.00663	CcSEcCtD
Prednicarbate—Pruritus—Sunitinib—pancreatic cancer	0.00662	0.00662	CcSEcCtD
Prednicarbate—Pain—Irinotecan—pancreatic cancer	0.00659	0.00659	CcSEcCtD
Prednicarbate—Pain—Gemcitabine—pancreatic cancer	0.00642	0.00642	CcSEcCtD
Prednicarbate—Pain—Fluorouracil—pancreatic cancer	0.00632	0.00632	CcSEcCtD
Prednicarbate—Rash—Sunitinib—pancreatic cancer	0.0059	0.0059	CcSEcCtD
Prednicarbate—Dermatitis—Sunitinib—pancreatic cancer	0.0059	0.0059	CcSEcCtD
Prednicarbate—Urticaria—Fluorouracil—pancreatic cancer	0.00587	0.00587	CcSEcCtD
Prednicarbate—Oedema—Docetaxel—pancreatic cancer	0.00533	0.00533	CcSEcCtD
Prednicarbate—Pruritus—Gemcitabine—pancreatic cancer	0.00531	0.00531	CcSEcCtD
Prednicarbate—Infection—Docetaxel—pancreatic cancer	0.0053	0.0053	CcSEcCtD
Prednicarbate—Pruritus—Fluorouracil—pancreatic cancer	0.00523	0.00523	CcSEcCtD
Prednicarbate—Rash—Irinotecan—pancreatic cancer	0.00486	0.00486	CcSEcCtD
Prednicarbate—Dermatitis—Irinotecan—pancreatic cancer	0.00486	0.00486	CcSEcCtD
Prednicarbate—Paraesthesia—Docetaxel—pancreatic cancer	0.00479	0.00479	CcSEcCtD
Prednicarbate—Rash—Gemcitabine—pancreatic cancer	0.00474	0.00474	CcSEcCtD
Prednicarbate—Dermatitis—Gemcitabine—pancreatic cancer	0.00473	0.00473	CcSEcCtD
Prednicarbate—Rash—Fluorouracil—pancreatic cancer	0.00466	0.00466	CcSEcCtD
Prednicarbate—Dermatitis—Fluorouracil—pancreatic cancer	0.00465	0.00465	CcSEcCtD
Prednicarbate—Pain—Docetaxel—pancreatic cancer	0.00456	0.00456	CcSEcCtD
Prednicarbate—Pruritus—Docetaxel—pancreatic cancer	0.00377	0.00377	CcSEcCtD
Prednicarbate—Oedema—Epirubicin—pancreatic cancer	0.0036	0.0036	CcSEcCtD
Prednicarbate—Infection—Epirubicin—pancreatic cancer	0.00357	0.00357	CcSEcCtD
Prednicarbate—Rash—Docetaxel—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Prednicarbate—Dermatitis—Docetaxel—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Prednicarbate—Oedema—Doxorubicin—pancreatic cancer	0.00333	0.00333	CcSEcCtD
Prednicarbate—Infection—Doxorubicin—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Prednicarbate—Paraesthesia—Epirubicin—pancreatic cancer	0.00323	0.00323	CcSEcCtD
Prednicarbate—Pain—Epirubicin—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Prednicarbate—Paraesthesia—Doxorubicin—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Prednicarbate—Urticaria—Epirubicin—pancreatic cancer	0.00286	0.00286	CcSEcCtD
Prednicarbate—Pain—Doxorubicin—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Prednicarbate—Urticaria—Doxorubicin—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Prednicarbate—Pruritus—Epirubicin—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Prednicarbate—Pruritus—Doxorubicin—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Prednicarbate—Rash—Epirubicin—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Prednicarbate—Dermatitis—Epirubicin—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Prednicarbate—Rash—Doxorubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Prednicarbate—Dermatitis—Doxorubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
